Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

958
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
958
Glaucoma: Overview01:25

Glaucoma: Overview

1.2K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.2K
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.1K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tattoo Granuloma Associated With Uveitis: A Useful Temporary Entity Pending Further Clarification-Response.

Clinical & experimental ophthalmology·2026
Same author

Expert consensus on fundus fluorescein angiography reporting in ophthalmology: a Delphi study.

The British journal of ophthalmology·2026
Same author

Rosacea scleritis and sclero-uveitis; under recognised and over treated.

Journal of ophthalmic inflammation and infection·2026
Same author

Methodological Limitations in Prognostic Modelling for Refractory Vogt-Koyanagi-Harada Disease: Response.

Clinical & experimental ophthalmology·2026
Same author

Ophthalmic Adverse Events of Systemic Immunotherapy and Targeted Cancer Therapy: A Review.

Clinical & experimental ophthalmology·2026
Same author

Intravitreal Ranibizumab Injections Significantly Influence Retinal Venous Calibre in Patients With Diabetic Macular Oedema.

Journal of ophthalmology·2026
Same journal

Increasing Evidence for the Utility of Red-Light Therapy and High Concentration Atropine in Myopia Control.

Clinical & experimental ophthalmology·2026
Same journal

Australian and New Zealand Glaucoma Society (ANZGS) Consensus on Interventional Glaucoma.

Clinical & experimental ophthalmology·2026
Same journal

Biopsy of Iris and Anterior Chamber Tumours: Fine Needle, Minimally Invasive and Excision Techniques - Review.

Clinical & experimental ophthalmology·2026
Same journal

Ray-Tracing-Based Intraocular Lens Power Calculation in Combined Cataract Surgery and Descemet Membrane Endothelial Keratoplasty.

Clinical & experimental ophthalmology·2026
Same journal

Comparative Efficacy of Two Defocus Soft Contact Lenses on Axial Length and Choroid in High Myopic Adolescents: Comment.

Clinical & experimental ophthalmology·2026
Same journal

Lessons Learnt From 25 Years of Endophthalmitis: Causes, Microbiology and Visual Outcome Trends.

Clinical & experimental ophthalmology·2026
See all related articles

Related Experiment Video

Updated: Jan 14, 2026

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

3.1K

Tattoo-Associated Uveitis: An Emerging Eye Health Challenge.

Ezann Siebert1, Verity Moynihan1, Noha Ali2,3,4

  • 1Royal Perth Hospital, Perth, Western Australia, Australia.

Clinical & Experimental Ophthalmology
|October 22, 2025
PubMed
Summary
This summary is machine-generated.

Tattoo-associated uveitis, an immune reaction to tattoo ink, is increasingly seen in Australian clinics. Many patients require long-term immunosuppression, highlighting a significant public eye health concern.

Keywords:
sarcoidscleritistattoo pigmenttattoo‐associated uveitisuveitis

More Related Videos

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

6.0K
Skin Tattooing As A Novel Approach For DNA Vaccine Delivery
06:37

Skin Tattooing As A Novel Approach For DNA Vaccine Delivery

Published on: October 18, 2012

16.6K

Related Experiment Videos

Last Updated: Jan 14, 2026

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis
10:33

Primed Mycobacterial Uveitis PMU as a Model for Post-Infectious Uveitis

Published on: December 17, 2021

3.1K
Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

6.0K
Skin Tattooing As A Novel Approach For DNA Vaccine Delivery
06:37

Skin Tattooing As A Novel Approach For DNA Vaccine Delivery

Published on: October 18, 2012

16.6K

Area of Science:

  • Ophthalmology
  • Immunology
  • Public Health

Background:

  • Tattoo-associated uveitis is a potentially sight-threatening condition linked to immune responses against tattoo ink.
  • Increasing tattoo popularity may correlate with rising case numbers.
  • Australian uveitis specialists are defining this emerging clinical entity.

Purpose of the Study:

  • To characterize tattoo-associated uveitis cases.
  • To define the clinical features, treatment, and outcomes.
  • To assess the public health implications of this condition.

Main Methods:

  • A multicentre retrospective case review was conducted by Australian uveitis specialists.
  • Data were collected from January 2023 to January 2025.
  • Patients were recruited from public and private practices, with demographic, clinical, and treatment data gathered.

Main Results:

  • Forty cases of tattoo-associated uveitis were identified, predominantly in young adults (52.5%) of Caucasian/European ethnicity (70%).
  • Most cases presented as bilateral (95%) anterior uveitis (70%), with inflammation often linked to black ink.
  • Systemic treatment, including steroid-sparing immunosuppression (62.5%) and biological DMARDs (42.5%), was frequently required; only 27.5% achieved remission off treatment.

Conclusions:

  • Tattoo-associated uveitis is now a recognized entity in Australian clinics, affecting vision in many patients.
  • A significant majority (63%) require long-term immunosuppression, including biological DMARDs.
  • This condition represents a growing public eye health issue, particularly in populations with high tattoo prevalence.